Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments

Journal of Clinical Psychopharmacology

Volumn 18, Issue 3, 1998, Pages 222-230

  Pérez, Victor ^b   Bel, Nuria ^a   Celada, Pau ^a   Ortiz, Jordi ^c   Alvarez, Enric ^b   Artigas, Francesc ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; CLOMIPRAMINE; FLUVOXAMINE; PHENELZINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE; TRYPTOPHAN;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DISEASE CLASSIFICATION; DRUG EFFECT; FEMALE; HUMAN; MALE; MELANCHOLIA; PATIENT CODING; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; SEASONAL VARIATION; SEROTONIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; BLOOD PLATELETS; CLOMIPRAMINE; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUVOXAMINE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEROTONIN; THIAZEPINES; TRYPTOPHAN;

EID: 0345215154     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199806000-00007     Document Type: Article

References (52)

1. Pletscher A, Laubscher A. Blood platelets as models for neurons: uses and limitations. J Neural Transm 1980;16:7-16.
2. Stahl SM, Meltzer HY. A kinetic and pharmacologic analysis of 5-hydroxytryptamine transport by human platelets and platelet storage granules: comparison with central serotonergic neurons. J Pharmacol Exp Ther 1978;205:118-32.
3. Laubscher A, Pletscher A. Uptake of 5-hydroxytryptamine in blood platelets and its inhibition by drugs: role of plasma membrane and granular storage. J Pharm Pharmacol 1979;31:284-9.
4. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994;40:288-95.
5. Blakely RD, Berson HE, Fremeau RT, Caron MG, Peek MM, Prince HK, Bradley CC. Cloning and expression of a functional serotonin transporter from rat brain. Nature 1991;354:66-70.
6. Lesch KP, Wolozin BL, Estler HC, Murphy DL, Riederer P. Isolation of a cDNA encoding the human brain serotonin transporter. J Neural Transm 1993;91:67-72.
7. Lesch KP, Wolozin BL, Murphy DL, Riederer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 1993;60:2319-22.
8. Tuomisto J, Tukiainen E, Ahlfors UG. Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression. Psychopharmacology 1979;65:141-7.
9. 3H-imipramine binding: a new biological tool for studies in depression. Trends Neurosci 1981;4: 29-31.
10. Caldecott-Hazard S, Morgan DG, DeLeon-Jones F, Overstreet DH, Janowsky D. Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories. Synapse 1991;9: 251-301.
11. Mellerup E, Langer SZ, Collaborative Authors. Validity of imipramine platelet binding sites as a biological marker of endogenous depression. Pharmacopsychiatry 1990;23:113-7.
12. Nemeroff CB, Knight DL, Franks J, Craighead WE, Krishnan KRR. Further studies on platelet serotonin transporter binding in depression. Am J Psychiatry 1994;151:1623-5.
13. 3H)5-HT uptake in human blood platelets: changes after one week chlorimipramine treatment. Eur J Pharmacol 1984;106: 629-33.
14. Ortiz J, Artigas F, Gelpi E. Serotonergic status in human blood. Life Sci 1988;43:983-90.
15. Gillis CN, Pitt BR. The fate of circulating amines within the pulmonary circulation. Annu Rev Physiol 1982;44:269-81.
16. 3H) norepinephrine in vivo: effects of pretreatment with imipramine or cocaine. J Pharmacol Exp Ther 1980;213:120-7.
17. Ortiz J, Artigas F. Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine. Br J Pharmacol 1992;105:941-6.
18. Anderson GM, Young JG, Cohen DJ, Schlich KR, Patel N. Liquid-chromatographic determination of serotonin and tryptophan in whole blood and plasma. Clin Chem 1981;27:775-6.
19. Fowler CJ, Tipton KF. Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase in the rat brain. J Neurochem 1982;38:733-6.
20. Celada P, Artigas F. Plasma 5-hydroxyindoleacetic acid as an indicator of MAO-A inhibition in brain and peripheral tissues. J Neurochem 1993;61:2191-8.
21. Marsden CA, Tyrer P, Casey P, Seiveweight N. Changes in human whole blood 5-hydroxytryptamine (5-HT) and platelet 5-HT uptake during treatment with paroxetine, a selective 5-HT uptake inhibitor. J Psychopharmacol 1987;1:244-50.
22. Sarrias MJ, Artigas F, Martinez E, Gelpi E, Alvarez E, Udina CC, Casas M. Decreased plasma serotonin in melancholic patients: a study with clomipramine. Biol Psychiatry 1987;22:1429-38.
23. Hyttel J, Overo KF, Arnt J. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. J Psychopharmacol 1984;83:20-7.
24. Celada P, Dolera M, Alvarez E, Artigas F. Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients, relationship to clinical improvement. J Affect Disord 1992;25:243-50.
25. Celada P, Perez J, Alvarez E, Artigas F. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement. J Clin Psychopharmacol 1992;12:309-15.
26. Cook EH, Leventhal BL, Freedman DX. Free serotonin in plasma: autistic children and their first-degree relatives. Biol Psychiatry 1988;24:488-91.
27. Fichtner CG, Arora RFL, Crayton JW. Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder preliminary observations on a possible predictor of clinical treatment response. Life Sci 1994;54:PL39-PL44.
28. Karege F, Widner J, Bovier P, Gaillard JM. Platelet serotonin and plasma tryptophan in depressed patients: effect of drug treatment and clinical outcome. Neuropsychopharmacology 1994;10:207-14.
29. Spreux-Varoquaux O, Gailledreau J, Vanier B, Bothua D, Plas J, Chevalier JF, Advenier C, Pays M, Brion S. Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine? Biol Psychiatry 1996;40:465-73.
30. Ortiz J, Mariscot C, Alvarez E, Artigas F. Effects of the antidepressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls. J Affect Disord 1993; 29:227-34.
31. Artigas F, Sarrias MJ, Martinez E, Gelpi E. Serotonin in body fluids: characterization of human plasmatic and cerebrospinal fluid pools by means of a new HPLC method. Life Sci 1985;37:441-7.
32. Ahlman H, Dahlström A. Vagal mechanisms controlling serotonin release from the gastrointestinal tract and pyloric motor function. J Auton Nerv Syst 1983;9:119-40.
33. Schworer H, Racke K, Kilbinger H. Holinergic modulation of the release of 5-hydroxytryptamine from the guinea pig ileum. Naunyn-Schmiedebergs Arch Pharmacol 1987;336:127-32.
34. Racke K, Schworer H, Kilbinger H. Adrenergic modulation of the release of 5-hydroxytryptamine from the vascular perfused ileum of the guinea-pig. Br J Pharmacol 1988;95:923-31.
35. Simon C, Temaux JP. Regulation of serotonin release from enterochromoffin cells of rat cecum mucosal. J Pharmacol Exp Ther 1990;253:825-32.
36. Schworer H, Racke K, Kilbinger H. GABA receptors are involved in the modulation of the release of 5-hydroxytryotamine from the vascularly perfused small intestine of the guinea pig. Eur J Pharmacol 1989;165:29-37.
37. Racke K, Reimann A, Schworer H, Kilbinger R Regulation of 5 HT release from enterochromaffin cells. Behav Brain Res 1995;73:83-7.
38. Asberg M, Bertilsson L, Martensson B, Scalia-Tomba GP, Trorén P, Traskman-Bendz L. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 1984;69:201-19.
39. Carboni E, Di Chiara G. Serotonin release estimated by transcortical dialysis in freely-moving animals. Neuroscience 1989;32: 637-45.
40. Charney DS, Heninger GR, Sternberg DE. Serotonin function and mechanism of action of antidepressant treatment. Arch Gen Psychiatry 1984;41:359-65.
41. Bel N, Artigas F. Reduction of serotonergic function in rat brain by tryptophan depletion. Effects in control and fluvoxamine-treated rats. J Neurochem 1996;67:669-76.
42. Crespi F, Garratt JC, Sleight AJ, Marsden CA. In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism. Neuroscience 1990;35:139-44.
43. Sarrias MJ, Cabré P, Martínez E, Artigas F. Relationship between serotoninergic measures in blood and cerebrospinal fluid simultaneously obtained in humans. J Neurochem 1990;54:783-6.
44. Mann JJ, McBride PA, Brown RP, Linnoila M, Leon AC, DeMeo M, Mieczkowski T, Myers JE, Stanley M. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry 1992;49:442-6.
45. Nielsen DA, Goldman D, Virkkunen M, Tokola T, Rawlings R, Linnoila M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry 1994;51:34-8.
46. Mennini T, Mocaer E, Garattini S, Tianeptine A. Selective enhancer of serotonin uptake in rat brain. Naunyn Schmiedebergs Arch Pharmacol 1987;336:478-82.
47. Artigas F, Pérez V, Figueras G, San Martino O, Grupo de Trastronos Afectivos (collaborative authors). Platelet 5-HT concentration and response to paroxetine. Abstracts of the Xth World Congress of Psychiatry; August 23-28, 1996; Madrid, Spain.
48. Castrogiovanni P, Di Muro A, Marazitti D. Imipramine binding as a predictor of fluoxetine response in depressed patients. Neuropsychobiology 1995;31:64-7.
49. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621-4.
50. Jernej B, Cicin-Sain L. Platelet serotonin level in rats is under genetic control. Psychiatry Res 1990;32:167-74.
51. Jernej B, Cicin-Sain L. Genetic alterations of serotonin uptake kinetics in rat platelets. Biol Psychiatry 1991;29:601S.
52. Romero L, Jernej B, Bel N, Cicin-Sain L, Cortes R, Artigas F. Basal and stimulated extracellular serotonin concentration in the brain of rats with altered serotonin uptake. Synapse 1998;28:313-21.